Literature DB >> 16916645

UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.

Yuichi J Machida1, Yuka Machida, Yuefeng Chen, Allan M Gurtan, Gary M Kupfer, Alan D D'Andrea, Anindya Dutta.   

Abstract

The Fanconi anemia pathway is required for the efficient repair of damaged DNA. A key step in this pathway is the monoubiquitination of the FANCD2 protein by the ubiquitin ligase (E3) composed of Fanconi anemia core complex proteins. Here, we show that UBE2T is the ubiquitin-conjugating enzyme (E2) essential for this pathway. UBE2T binds to FANCL, the ubiquitin ligase subunit of the Fanconi anemia core complex, and is required for the monoubiquitination of FANCD2 in vivo. DNA damage in UBE2T-depleted cells leads to the formation of abnormal chromosomes that are a hallmark of Fanconi anemia. In addition, we show that UBE2T undergoes automonoubiquitination in vivo. This monoubiquitination is stimulated by the presence of the FANCL protein and inactivates UBE2T. Therefore, UBE2T is the E2 in the Fanconi anemia pathway and has a self-inactivation mechanism that could be important for negative regulation of the Fanconi anemia pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916645     DOI: 10.1016/j.molcel.2006.06.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  137 in total

Review 1.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

Review 2.  Ubiquitin signalling in DNA replication and repair.

Authors:  Helle D Ulrich; Helen Walden
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-16       Impact factor: 94.444

3.  ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death.

Authors:  Lilliana Radoshevich; Lyndsay Murrow; Nan Chen; Estefania Fernandez; Srirupa Roy; Christopher Fung; Jayanta Debnath
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

4.  UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination.

Authors:  Arno Alpi; Frederic Langevin; Georgina Mosedale; Yuichi J Machida; Anindya Dutta; Ketan J Patel
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

5.  FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.

Authors:  Chen Ling; Masamichi Ishiai; Abdullah Mahmood Ali; Annette L Medhurst; Kornelia Neveling; Reinhard Kalb; Zhijiang Yan; Yutong Xue; Anneke B Oostra; Arleen D Auerbach; Maureen E Hoatlin; Detlev Schindler; Hans Joenje; Johan P de Winter; Minoru Takata; Amom Ruhikanta Meetei; Weidong Wang
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

6.  Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24.

Authors:  Jung Min Kim; Younghoon Kee; Allan Gurtan; Alan D D'Andrea
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

Review 7.  Fanconi anaemia and the repair of Watson and Crick DNA crosslinks.

Authors:  Molly C Kottemann; Agata Smogorzewska
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  DUB-resistant ubiquitin to survey ubiquitination switches in mammalian cells.

Authors:  Miklós Békés; Keiji Okamoto; Sarah B Crist; Mathew J Jones; Jessica R Chapman; Bradley B Brasher; Francesco D Melandri; Beatrix M Ueberheide; Eros Lazzerini Denchi; Tony T Huang
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

Review 9.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

10.  Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.

Authors:  Wenrui Duan; Li Gao; Weiqiang Zhao; Marino Leon; Wolfgang Sadee; Amy Webb; Kimberly Resnick; Xin Wu; Bhuvaneswari Ramaswamy; David E Cohn; Charles Shapiro; Paul R Andreassen; Gregory A Otterson; Miguel A Villalona-Calero
Journal:  Transl Res       Date:  2012-10-11       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.